DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20163223

A prospective cohort study to evaluate the correlates of polypharmacy and its association with depression among elderly patients

Shweta Srivatsa, Debdipta Bose, Sushma M., Jayanthi C. R.

Abstract


Background: Polypharmacy is a reliable indicator of irrational prescribing particularly among elderly. Polypharmacy increases the risk of adverse drug reactions (ADRs) exponentially imposing higher economic burden. Addressing and evaluating the prescribing practices in elderly will rationalize the drug utilization leading to improvement in quality of health care. The present study was taken to evaluate the determinants of polypharmacy and its association with depression, defined as a 15 item geriatric depression scale (GDS) >6, in elderly patients.

Methods: This prospective cohort study was conducted at department of medicine, Victoria hospital, Bengaluru 100 patients aged 60 and above years was enrolled. Relevant data regarding patients’ demographic details, smoking and alcohol consumption, medical diagnosis and drug details were collected. Geriatric Depression Scale was used to diagnose depression.

Results: Out of 100 patients screened, 36% were males and 64% were females. Polypharmacy was noted in 73% of the elderly, of which 43% had cumulative co morbidity (≥4 diagnoses).  68% were found to have a GDS score of ≥6, which corresponded to Depression. Patients with depression (GDS score ≥6) had 1.54 (OR-1.54, 95% CI-0.59-4.01) times more risk of encountering polypharmacy (≥4 drugs). Cumulative co-morbidity (OR-1.52, 95% CI-1.08–2.11, p <0.05) was identified as an independent correlate of polypharmacy.

Conclusions: Increasing age, males, Cumulative comorbidity of ≥4 diagnoses and geriatric depression were found to be the positive correlates of polypharmacy in elderly. Though geriatric depression increases the odds of encountering polypharmacy, it does not affect drug consumption directly; rather it is an important index of cumulative co-morbidity which influences polypharmacy significantly.


Keywords


Elderly, Polypharmacy, Geriatric depression Score, Cumulative co morbidity

Full Text:

PDF

References


Somers A, Petrovic M, Robays H. Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol. 2003;58:707-14.

Antonelli Incalzi R, Corsonello A, Pedone C. Depression and drug utilization in an older population. Ther Clin Risk Manag. 2005;1:55-60.

Corsonello A, Pedone C, Corica F, Antonelli Incalzi R. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag. 2007;3(1):197-203.

Mulsant BH, Ganguli M, Seaberg. Thc rc!aticnship-between selt~ rated health and depressive symptoms in an epidemiological sample of community-dwelling older adults. Journal of the American Geriatric Society. 1997;45(8):954-8.

Simons LA, Tett S, Simons J. Multiple medication use in the elderly. Use of prescription and non-prescription drugs in an Australian community setting. Med J Aust .1992;157:242-6.

Lesher EL, Berryhill JS. Validation of the Geriatric Depression Scale–Short Form among inpatients. J Clin Psychol. 1994;50:256-60.

Ayesha R, Laxminarayana K, Astha Sarda, Sushma M, Jayanthi CR. Polypharmacy leading to adverse drug reactions in elderly in a tertiary care hospital. Int J Pharm Bio Sci. 2012;3(3):218-24.

Chan DC, Hao YT, Wu SC. Characteristics of outpatient prescriptions for frail Taiwanese elders with long-term care needs. Pharm Drug Saf. 2009;18(4):327–34.

Al Ameri MN, Makramalla E, Albur U, Kumar A, Rao P. Prevalence of Poly-pharmacy in the Elderly: Implications Page 4 of 7 of Age, Gender, Co-morbidities and Drug Interactions. SOJ Pharm Pharm Sci. 2014;1(3):1-7.

Pilania M, Bairwa M, Kumar N, Khanna P, Khurana H. Elderly depression in India: An emerging public health challenge. AMJ. 2013;6(3):107-11.

Mili D. Prevalence and risk factors of polypharmacy among elderly in India: Evidence from SAGE Data. International Journal of Public Mental Health & Neurosciences. 2015;2(2):11-16.

Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.

Raghupathy A, Nanda KK, Hira P, Hassan K, Oscar FH, Di Emanuele A, et al. Hypertension in India: a systemic review and meta-analysis of prevalence, awareness, and control of hypertension. Journal of Hypertension. 2014;32(6):1170-7.

Veena DR, Padma L, Sapna P. Drug prescribing pattern in elderly patients in a teaching hospital. Journal of Dental and Medical Sciences. 2012;1(5):39-42.

Joseph FO, Segun AM, Olumide OA, Rachel AA. Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital. Ther Clin Risk Manag. 2013;9:115-20.

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. AMJ. 2014;7(1):45-8.

Chester GB. Polypharmacy in elderly patients with diabetes. Diabetes Spectrum. 2002;15(4):240-8.

Vyas A, Pan X, Sambamoorthi U. Chronic Condition Clusters and Polypharmacy among Adults. Int J Fam Med. [Internet]. 2012 Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3415173/. Accessed on June 2016.

Bhamani MA, Karim MS, Khan MM. Depression in elderly in Karachi, Pakistan: a cross sectional study. BMC Psychiatry. 2013;13:18.

Stafford L, Berk M, Jackson HJ. Tobacco smoking predicts depression and poorer quality of life in heart disease. BMC Cardiovasc Disord. 2013;13:2-10.

Wong SYS, Mercer SW, Jean W, Jason L. The influence of multi morbidity and self-reported socio economic standing on the prevalence of depression in an elderly Hong Kong population. BMC Public health. 2008;8:119.

Macready N. Los Angeles Bureau. Polypharmacy May Be Linked to Depression in the Elderly. www.eclinicalpsychiatrynews.com. Accessed on Jan 2005.